Werkgroep Cardiologische centra Nederland English

ARTS-HF (Klaar)

A randomized, double-blind, double-dummy, multi-center study to assess safety and efficacy of different oral doses of BAY 94-8862 in subjects with emergency admittance to the hospital because of worsening chronic heart failure with left ventricular systolic dysfunction and type 2 diabetes mellitus and / or chronic kidneydisease versus eplerenone.

Middel
BAY 94-8862
Populatie
hartfalen
Fase
IIb
Jaar aanvang
2012
Meer informatie
ClinicalTrials.gov

Studiedirecteur

drs. P.R. Nierop (Cardioloog)
Rotterdam, Franciscus Gasthuis